PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Genomic test shows promise as chemotherapy response, survival predictor for women with breast cancer

Tool may one day be used to guide patients' treatment with standard therapy alone, or personalized clinical trial upfront

2011-05-11
(Press-News.org) HOUSTON — A new genomic test combining multiple signatures – a patient's estrogen receptor status, endocrine therapy response, chemotherapy resistance and sensitivity – shows promise as a predictor of chemotherapy response and survival benefit in women with invasive breast cancer, according to research led by The University of Texas MD Anderson Cancer Center.

The findings, published in the May 11 issue of JAMA, also may determine those for whom standard therapy alone might not offer enough, and/or for whom an appropriate clinical trial in the adjuvant setting could provide additional benefit.

"The research builds on a decade of collaborative work in developing a clinically meaningful chemotherapy predictor, and, if validated in future studies, could guide therapy for about 80 percent of newly diagnosed women with invasive breast cancer who are candidates for chemotherapy," says W. Fraser Symmans, MD, professor in MD Anderson's Department of Pathology.

"The test helps us understand both resistance and response to chemotherapy more specifically, how sensitivity to endocrine therapy would impact a predictor and how to focus on specific subtypes of breast cancer – in this case HER2 negative disease stratified by estrogen receptor (ER) status – because we've learned that they are so intrinsically different," Symmans continues.

The multicenter study enrolled 310 Stage II and III newly diagnosed women with invasive breast cancer (discovery cohort). All were Her2 negative and received the chemotherapy regimen of sequential taxane and anthracycline, followed by endocrine therapy, if hormone receptor positive. Gene expression microarrays from the discovery cohort were used to develop different predictive signatures for drug resistance and response. Using the signatures for endocrine therapy response, chemotherapy resistance and sensitivity, in combination with other genomic predictors to chemotherapy response, breast cancer treatment was predicted in an independent cohort of 198 breast cancer patients with similar diagnosis and treatment (independent cohort).

The study's primary endpoint was distant relapse-free survival (DRFS) and absolute risk reduction (ARR) and the median follow up was three years. Excluding women with known endocrine sensitivity, the algorithm had a positive predictive value (PPV) of 56 percent. In the 28 percent who were predicted treatment-sensitive, their three-year DRFS was 92 percent, ARR was18 percent and they had a five-fold reduction of risk of distant relapse.

When analyzed by ER status, treatment sensitivity was predicted in 30 percent of the ER-positive women and in 26 percent of those who were ER-negative. At three year follow up, DRFS and ARR was 97 percent and 11 percent, respectively, in the ER-positive cohort, compared to 83 percent and 26 percent, respectively, in the ER-negative cohort.

"From a therapeutic standpoint, we know that the treatment a patient receives at initial diagnosis offers the greatest chance for cure. At the same time, we have many potential clinical trials with novel therapeutics and targeted agents in breast cancer. Currently, we're still not sure who we are curing with chemotherapy and who also could benefit from these novel therapies," says Lajos Pusztai, M.D., D.Phil, professor in the Department of Breast Medical Oncology and an author on the study.

If validated in future studies, these findings could be used as a treatment gatekeeper, explains Pusztai, guiding women and their physicians by affirming the selection of standard chemotherapy or, for those at greater risk for recurrence, to a potentially therapeutic clinical trial in the adjuvant setting, from which they may gain further clinical benefit.

### The study was funded by grants from Susan G. Komen for the Cure, the Breast Cancer Research Foundation and the National Cancer Institute.

In addition to Symmans and Pusztai, other MD Anderson authors on the study include: Gabriel Hortobagyi, M.D., professor and chair; Vicente Valero, M.D., professor; Daniel J. Boosier, M.D., professor; Nuhad Ibrahim, M.D., professor; and Naoto Uneo, M.D., Ph.D., professor; Eleni Andreopoulou, M.D., assistant professor, all with the Department of Breast Medical Oncology; Yun Gong, M.D., associate professor, Yun Wu, M.D., Ph.D., assistant professor, Rebekkah Hubbard, all with the Department of Pathology; Kelly Hunt, M.D., professor, department of surgery; Wei Yang, M.D., professor, Department of Diagnostic Radiology; Arlene Nazario, M.D., clinical associate professor, Department of General Oncology. Other authors on the study include: Laura Esserman, M.D., M.B.A.; Ana Lluch, M.D.; Tatiana Vidaurre, M.D.; Frankie Holmes, M.D.; Eduardo Souchon, M.D.; Hongkun Wang, Ph.D.; Miguel Martin, M.D.; José Cotrina, M.D.; Henry Gomez, M.D.; Ignacio Chacon, M.D.; Jaime Ferrer-Lozano, M.D.; Richard Dyer, M.D.; Meredith Buxton; Angela DeMichele, M.D.; and Joyce O'Shaughnessy, M.D.

MD Anderson owns a portion of Nuvera Biosciences. The following MD. Anderson authors have potential conflicts to disclose: Symmans, unpaid scientific advisor for, and equity in, Nuvera Biosciences, patents with royalties and honoraria from Agendia BV; Pusztai, unpaid scientific advisor for, and patents with, Nuvera Biosciences; Hortobagyi, paid consultant for Allergan, Genentech, Novartis and Sanofi-Aventis, and research funding from Novartis.

About MD Anderson The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For seven of the past nine years, including 2010, MD Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.


ELSE PRESS RELEASES FROM THIS DATE:

'Surrogates' aid design of complex parts and controlling video games

Surrogates aid design of complex parts and controlling video games
2011-05-11
WEST LAFAYETTE, Ind. - Researchers have defined a new class of software, calling it "surrogate interaction," which enables designers and video gamers to more easily change features of complex objects like automotive drawings or animated characters. The new interactive approach is being used commercially and in research but until now has not been formally defined, and doing so could boost its development and number of applications, said Ji Soo Yi, an assistant professor of industrial engineering at Purdue University. Conventional computer-aided design programs often ...

Genetic defects hold clues to risk for sudden cardiac death

2011-05-11
Sudden cardiac death is always a shocking, tragic event, especially when it occurs at a young age. But, for the first time, scientists are unraveling how genetic defects can help predict the risk of dying suddenly in individuals with one of the leading causes of this unfortunate phenomenon. This knowledge could guide treatment and potentially lessen the occurrence of sudden cardiac death in patients with Long QT syndrome, a rare, inherited heart rhythm disorder. It could also provide insight into the assessment and treatment of the millions of people who experience cardiac ...

Wayne State researchers find new way to examine major depressive disorder in children

2011-05-11
DETROIT — A landmark study by scientists at Wayne State University published in the May 6, 2011, issue of Archives of General Psychiatry, the most prestigious journal in the field, has revealed a new way to distinguish children with major depressive disorder (MDD) from not only normal children, but also from children with obsessive compulsive disorder (OCD). MDD is a common, debilitating disease prevalent in childhood and adolescence. Examination of cortical thickness in patients with MDD has not been widely studied, and WSU's team of researchers set out to determine ...

Brazil's health care system vastly expands coverage, but universality, equity remain elusive

2011-05-11
Two decades after Brazil's constitution recognized health as a citizen's right and a duty of the state, the country has vastly expanded health care coverage, improved the population's health, and reduced many health inequalities, but universal and equitable coverage remains elusive, experts from four major Brazilian universities and New York University have concluded. According to their analysis—one of six articles published in the medical journal The Lancet as a special series on health in Brazil—while federal expenditures have nearly quadrupled over the past 10 years, ...

High-tech approach uses lights, action and camera to scrutinize fresh produce

2011-05-11
This release is available in Spanish. High-tech tactics to carefully examine apples and other fresh produce items as they travel along packinghouse conveyor belts will help ensure the quality and safety of these good-for-you foods. U.S. Department of Agriculture (USDA) scientists in Beltsville, Md., have developed and patented an experimental, cutting-edge optical scanning system that would use two different kinds of lighting, a sophisticated camera and other pieces of equipment to scrutinize produce-section favorites while they are still at the packinghouse. The ...

Training to promote health

Training to promote health
2011-05-11
This release is available in German. Marianne has constant pain in her right knee at the moment – she hurt it when she took a tumble skiing in the Swiss Alps. Everything happened so quickly: The searing pain, the helicopter ride to hospital, the operation the following day, and then a week later the return home with crutches to rest in a reclining chair. Her aim now is to mobilize the operated knee and regain full mobility of the joint – something she'll achieve by following a targeted machine-based training plan drawn up by a physiotherapist. In order to be able ...

Depression associated with poor medication adherence in patients with chronic illnesses

2011-05-11
People who are depressed are less likely to adhere to medications for their chronic health problems than patients who are not depressed, putting them at increased risk of poor health, according to a new RAND Corporation study. Researchers found that depressed patients across a wide array of chronic illnesses such as diabetes and heart disease had 76 percent greater odds of being non-adherent with their medications compared to patients who were not depressed. The findings were published online by the Journal of General Internal Medicine. The study is the largest systematic ...

Study: Lowering cost doesn't increase hearing aid purchases

Study: Lowering cost doesnt increase hearing aid purchases
2011-05-11
DETROIT – Lowering the cost of hearing aids isn't enough to motivate adults with mild hearing loss to purchase a device at a younger age or before their hearing worsens, according to researchers at Henry Ford Hospital. A new study shows that simply lowering the cost of hearing aids – even by as much as 40% – does not improve hearing aid purchase for patients with partial insurance coverage or those who need to cover the entire cost out of pocket. Only patients with full insurance coverage for hearing aids get them at a younger age and with significantly less hearing ...

Zebrafish models identify high-risk genetic features in leukemia patients

2011-05-11
SALT LAKE CITY—Leukemia is the most common childhood cancer; it also occurs in adults. Now researchers working with zebrafish at Huntsman Cancer Institute (HCI) at the University of Utah have identified previously undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia (T-ALL), according to an article published online May 9, 2011, in the cancer research journal Oncogene. When compared to samples from human patients with T-ALL, these genetic characteristics allowed scientists to predict which patients may have more aggressive forms of the disease that ...

2 new studies describe likely beneficiaries of health care reform in California

2011-05-11
According to two new policy briefs from the UCLA Center for Health Policy Research, the majority of state residents likely to be eligible for federally mandated health insurance coverage initiatives in California in 2014 are also those who may be least likely to excessively use costly health services: men, singles and those of working age. As a result of last year's passage of the federal Patient Protection and Affordable Care Act (ACA), up to 4.57 million previously uninsured or underinsured Californians may be eligible for coverage, either through an expansion of ...

LAST 30 PRESS RELEASES:

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

[Press-News.org] Genomic test shows promise as chemotherapy response, survival predictor for women with breast cancer
Tool may one day be used to guide patients' treatment with standard therapy alone, or personalized clinical trial upfront